TY - JOUR
T1 - Improving mitochondria-associated endoplasmic reticulum membranes integrity as converging therapeutic strategy for rare neurodegenerative diseases and cancer
AU - Cagalinec, Michal
AU - Mohd, Adnan
AU - Borecka, Silvia
AU - Bultynck, Geert
AU - Choubey, Vinay
AU - Yanovsky-Dagan, Shira
AU - Ezer, Shlomit
AU - Gasperikova, Daniela
AU - Harel, Tamar
AU - Jurkovicova, Dana
AU - Kaasik, Allen
AU - Liévens, Jean Charles
AU - Maurice, Tangui
AU - Peviani, Marco
AU - Richard, Elodie Marie
AU - Skoda, Jan
AU - Skopkova, Martina
AU - Tarot, Pauline
AU - Van Gorp, Robbe
AU - Zvejniece, Liga
AU - Delprat, Benjamin
N1 - Publisher Copyright:
© 2025
PY - 2025/6/1
Y1 - 2025/6/1
N2 - Membrane contact sites harbor a distinct set of proteins with varying biological functions, thereby emerging as hubs for localized signaling nanodomains underlying adequate cell function. Here, we will focus on mitochondria-associated endoplasmic reticulum membranes (MAMs), which serve as hotspots for Ca2+ signaling, redox regulation, lipid exchange, mitochondrial quality and unfolded protein response pathway. A network of MAM-resident proteins contributes to the structural integrity and adequate function of MAMs. Beyond endoplasmic reticulum (ER)-mitochondrial tethering proteins, MAMs contain several multi-protein complexes that mediate the transfer of or are influenced by Ca2+, reactive oxygen species and lipids. Particularly, IP3 receptors, intracellular Ca2+-release channels, and Sigma-1 receptors (S1Rs), ligand-operated chaperones, serve as important platforms that recruit different accessory proteins and intersect with these local signaling processes. Furthermore, many of these proteins are directly implicated in pathophysiological conditions, where their dysregulation or mutation is not only causing diseases such as cancer and neurodegeneration, but also rare genetic diseases, for example familial Parkinson's disease (PINK1, Parkin, DJ-1), familial Amyotrophic lateral sclerosis (TDP43), Wolfram syndrome1/2 (WFS1 and CISD2), Harel-Yoon syndrome (ATAD3A). In this review, we will discuss the current state-of-the-art regarding the molecular components, protein platforms and signaling networks underlying MAM integrity and function in cell function and how their dysregulation impacts MAMs, thereby driving pathogenesis and/or impacting disease burden. We will highlight how these insights can generate novel, potentially therapeutically relevant, strategies to tackle disease outcomes by improving the integrity of MAMs and the signaling processes occurring at these membrane contact sites.
AB - Membrane contact sites harbor a distinct set of proteins with varying biological functions, thereby emerging as hubs for localized signaling nanodomains underlying adequate cell function. Here, we will focus on mitochondria-associated endoplasmic reticulum membranes (MAMs), which serve as hotspots for Ca2+ signaling, redox regulation, lipid exchange, mitochondrial quality and unfolded protein response pathway. A network of MAM-resident proteins contributes to the structural integrity and adequate function of MAMs. Beyond endoplasmic reticulum (ER)-mitochondrial tethering proteins, MAMs contain several multi-protein complexes that mediate the transfer of or are influenced by Ca2+, reactive oxygen species and lipids. Particularly, IP3 receptors, intracellular Ca2+-release channels, and Sigma-1 receptors (S1Rs), ligand-operated chaperones, serve as important platforms that recruit different accessory proteins and intersect with these local signaling processes. Furthermore, many of these proteins are directly implicated in pathophysiological conditions, where their dysregulation or mutation is not only causing diseases such as cancer and neurodegeneration, but also rare genetic diseases, for example familial Parkinson's disease (PINK1, Parkin, DJ-1), familial Amyotrophic lateral sclerosis (TDP43), Wolfram syndrome1/2 (WFS1 and CISD2), Harel-Yoon syndrome (ATAD3A). In this review, we will discuss the current state-of-the-art regarding the molecular components, protein platforms and signaling networks underlying MAM integrity and function in cell function and how their dysregulation impacts MAMs, thereby driving pathogenesis and/or impacting disease burden. We will highlight how these insights can generate novel, potentially therapeutically relevant, strategies to tackle disease outcomes by improving the integrity of MAMs and the signaling processes occurring at these membrane contact sites.
KW - ATAD3A related disorders
KW - Amyotrophic lateral sclerosis
KW - Calcium signaling
KW - Cancer
KW - Endoplasmic reticulum stress
KW - Familial Parkinson's disease
KW - Harel-Yoon syndrome
KW - Metabolomics
KW - Mitochondria quality control
KW - Mitochondria-associated endoplasmic reticulum membranes
KW - Rare neurodegenerative diseases
KW - Wolfram syndrome
UR - http://www.scopus.com/inward/record.url?scp=105003153358&partnerID=8YFLogxK
U2 - 10.1016/j.bbamcr.2025.119954
DO - 10.1016/j.bbamcr.2025.119954
M3 - Review article
C2 - 40216201
AN - SCOPUS:105003153358
SN - 0167-4889
VL - 1872
JO - Biochimica et Biophysica Acta - Molecular Cell Research
JF - Biochimica et Biophysica Acta - Molecular Cell Research
IS - 5
M1 - 119954
ER -